Pulse Biosciences Inc. (PLSE)
16.75
0.81 (5.08%)
At close: Apr 02, 2025, 3:59 PM
16.31
-2.61%
After-hours: Apr 02, 2025, 07:54 PM EDT
Pulse Biosciences Balance Sheet Statement
Financials in USD. Fiscal year
is
January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 |
Cash & Equivalents | 118.04M | 44.37M | 61.14M | 28.61M | 12.46M | 6.9M | 51.1M | 3.39M | 2.09M | 3.61M | 7.01M |
Short-Term Investments | n/a | n/a | n/a | n/a | 8.01M | 18.5M | 8.48M | 34.68M | 14.31M | n/a | n/a |
Long-Term Investments | n/a | n/a | -2.73M | -3.25M | -3.61M | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 677K | 365K | 365K | 365K | 365K | 494K | 101K | 101K | n/a | n/a | 9.78K |
Receivables | n/a | n/a | n/a | 61K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | 5.82M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 1.41M | 963K | 1.01M | 2.13M | n/a | n/a | n/a | n/a | n/a | 347K | n/a |
Total Current Assets | 119.45M | 45.33M | 62.15M | 36.63M | 22.34M | 26.4M | 60.36M | 38.48M | 16.66M | 4M | 7.03M |
Property-Plant & Equipment | 8.32M | 8.78M | 10.02M | 11.25M | 11.92M | 7.68M | 2.17M | 2.57M | 317K | 328.83K | 190.43K |
Goodwill & Intangibles | 4.01M | 4.68M | 5.34M | 6.01M | 6.67M | 7.34M | 8M | 8.67M | 9.33M | 10M | 10.66M |
Total Long-Term Assets | 13.01M | 13.83M | 15.73M | 17.62M | 18.95M | 15.51M | 10.28M | 11.34M | 9.65M | 10.33M | 10.87M |
Total Assets | 132.46M | 59.15M | 77.88M | 54.25M | 41.29M | 41.91M | 70.64M | 49.82M | 26.31M | 14.33M | 17.9M |
Account Payables | 1.67M | 1.84M | 1.57M | 2.9M | 1.72M | 1.96M | 1.27M | 782K | 265K | 262K | 33.28K |
Deferred Revenue | n/a | n/a | n/a | 16K | n/a | n/a | n/a | n/a | n/a | n/a | 39.49K |
Short-Term Debt | 1.35M | n/a | 917K | 436K | 542K | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 7.03M | 3.2M | 50K | 1.46M | 2.78M | 234K | 415K | 397K | n/a | 239.76K | 39.49K |
Total Current Liabilities | 10.05M | 6.71M | 5.98M | 8.52M | 7.58M | 4.46M | 3.11M | 2.21M | 1.02M | 659.76K | 164.81K |
Long-Term Debt | 7.54M | n/a | 65M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | 1.2M | 1.61M | n/a | n/a | n/a |
Total Long-Term Liabilities | 7.54M | 8.09M | 74.14M | 10.04M | 10.81M | 6.72M | 1.2M | 1.61M | 265K | 261.99K | 1.66M |
Total Liabilities | 17.6M | 14.79M | 80.13M | 18.56M | 18.4M | 11.18M | 4.31M | 3.83M | 1.02M | 659.76K | 1.82M |
Total Debt | 8.9M | 9.14M | 75.96M | 11.25M | 11.36M | 6.72M | n/a | n/a | n/a | n/a | n/a |
Common Stock | 66K | 55K | 37K | 29K | 25K | 21K | 142.05M | 84.22M | 13K | 7.57K | 7.57K |
Retained Earnings | -390.5M | -336.92M | -294.7M | -236.2M | -172.54M | -122.69M | -75.72M | -38.17M | -12.61M | -3.09M | -276.56K |
Comprehensive Income | n/a | n/a | -0.00 | n/a | -1K | 4K | -1K | -51K | -7K | -0.00 | 0.00 |
Shareholders Equity | 114.86M | 44.36M | -2.25M | 35.69M | 22.89M | 30.74M | 66.33M | 45.99M | 25.3M | 13.67M | 16.07M |
Total Investments | n/a | n/a | -2.73M | -3.25M | 8.01M | 18.5M | 8.48M | 34.68M | 14.31M | n/a | n/a |